ARCHIVES

Alimta Reduces Risk Of Progression In Patients Aged 70 Years or Older

This article is from The Cancer Letter archive.

Vol. 34 No. 10 | October 28, 2011

Download PDF Visit The Full Archive

Related Articles

Herceptin With Chemo Increases Survival In Early-Stage Breast Cancer, Study Finds

December 30, 2005

Mihich to Be Sixth New NCAB appointee; Centers Worried About Core Grants, Role In 200 AD Goals

May 25, 1984

NCI’s SBIR Paylines Nears Regular Grants

September 20, 1985

Young Reappointed BSA Chairman.

November 30, 2007

Merck Serono Cancels Tecemotide Program In NSCLC, Including Two Phase III Trials

September 26, 2014

Bush Names Leffall Cancer Panel Chairman, Appoints Cyclist Armstrong To Panel

May 31, 2002